Predicting progression from SeLECTS with SWAS to EE-SWAS: risk factor identification and model development
This study provides the first validated tool for early risk stratification in SWAS-associated SeLECTS, enabling clinicians to anticipate EE-SWAS progression and optimize therapeutic strategies. The model's robustness supports its potential utility in clinical decision-making to mitigate cognitive decline.
Authors
- Lingling Xie (ORCID: https://orcid.org/0000-0002-8115-5068)
- Ping Yuan (ORCID: https://orcid.org/0000-0002-6964-7449)
- Yu Deng
- Jiannan Ma (ORCID: https://orcid.org/0000-0003-2135-920X)
- Yuanyuan Luo
- Siqi Hong
- Qiao Hu
- Li Jiang
Institutions
- Children's Hospital of Chongqing Medical University (CN)
- Chongqing Medical University (CN)
Publication Details
- Journal
- Frontiers in Human Neuroscience
- Published
- 2026-01-15
- DOI
- https://doi.org/10.3389/fnhum.2025.1641421
- Primary Topic
- Epilepsy research and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- Natural Science Foundation of Chongqing